LeadIQ logo
Learn more at LeadIQ.com

Insights

Cell Therapy Market Entry Semma Therapeutics' acquisition by Vertex Pharmaceuticals in 2019 opens the door for introducing new cell therapy options to Vertex's existing market, creating potential sales opportunities for Semma's innovative diabetes treatment.

Strategic Partnerships for Growth Partnerships with industry giants like Medtronic, Novartis, and Vertex Pharmaceuticals position Semma to leverage their networks and resources for accelerated growth, presenting excellent sales collaboration prospects within a well-established ecosystem.

Financial Backing for Expansion Having attracted significant investments, including a $114 million Series B round, Semma Therapeutics possesses the financial resources required to expand operations, potentially leading to increased product offerings and sales opportunities in the biotechnology sector.

Key Leadership Influence With experienced leadership such as Ms. Fenton, who brings CFO expertise from Achillion Pharmaceuticals, Semma is guided by individuals well-versed in financial strategy, potentially enhancing sales effectiveness through sound fiscal decision-making and planning.

Competitive Landscape Advantage Comparative to similar biotech companies like Quell Therapeutics and Generation Bio, Semma's collaboration with Vertex Pharmaceuticals, along with its unique cell therapy approach for diabetes treatment, provides a competitive edge that can be leveraged to capture a larger market share and drive sales growth.

Similar companies to Semma Therapeutics

Semma Therapeutics Tech Stack

Semma Therapeutics uses 8 technology products and services including Joomla, Microsoft Outlook, Google Font API, and more. Explore Semma Therapeutics's tech stack below.

  • Joomla
    Content Management System
  • Microsoft Outlook
    Email
  • Google Font API
    Font Scripts
  • Font Awesome
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • PHP
    Programming Languages
  • Python
    Programming Languages
  • Minitab
    Visualisation Software

Media & News

Semma Therapeutics's Email Address Formats

Semma Therapeutics uses at least 1 format(s):
Semma Therapeutics Email FormatsExamplePercentage
F.Last@semma-tx.comJ.Doe@semma-tx.com
86%
FLast@semma-tx.comJDoe@semma-tx.com
8%
First.Last@semma-tx.comJohn.Doe@semma-tx.com
4%
FirstLas@semma-tx.comJohnDoe@semma-tx.com
2%

Frequently Asked Questions

Where is Semma Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Semma Therapeutics's main headquarters is located at 100 Technology Sq Cambridge, Massachusetts 02139 US. The company has employees across 4 continents, including North AmericaAsiaSouth America.

What is Semma Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Semma Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Semma Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Semma Therapeutics's official website is semma-tx.com and has social profiles on LinkedIn.

What is Semma Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Semma Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Semma Therapeutics have currently?

Minus sign iconPlus sign icon
As of April 2020, Semma Therapeutics has approximately 88 employees across 4 continents, including North AmericaAsiaSouth America. Key team members include Operations Manager: T. M.Senior Research Associate: E. T.Senior Scientist, Preclinical: J. O.. Explore Semma Therapeutics's employee directory with LeadIQ.

What industry does Semma Therapeutics belong to?

Minus sign iconPlus sign icon
Semma Therapeutics operates in the Biotechnology Research industry.

What technology does Semma Therapeutics use?

Minus sign iconPlus sign icon
Semma Therapeutics's tech stack includes JoomlaMicrosoft OutlookGoogle Font APIFont Awesomeyepnope.jsPHPPythonMinitab.

What is Semma Therapeutics's email format?

Minus sign iconPlus sign icon
Semma Therapeutics's email format typically follows the pattern of . Find more Semma Therapeutics email formats with LeadIQ.

How much funding has Semma Therapeutics raised to date?

Minus sign iconPlus sign icon
As of April 2020, Semma Therapeutics has raised $114M in funding. The last funding round occurred on Nov 01, 2017 for $114M.

When was Semma Therapeutics founded?

Minus sign iconPlus sign icon
Semma Therapeutics was founded in 2015.
Semma Therapeutics

Semma Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Semma Therapeutics is pioneering the new treatment paradigm of using cells as medicine.  Semma’s new class of regenerative medicine therapies couples its breakthrough stem cell technologies with proprietary delivery systems designed to protect cells from the immune system. Ongoing research at Semma Therapeutics is focused on combining these highly-differentiated active cells with a state-of-the-art device to provide a functional cure for patients with diabetes. Semma Therapeutics is working to bring new therapeutic options to the clinic and improve the lives of patients. The company is headquartered in Cambridge, MA, with operations in Providence, RI.  For more information, visit www.semma-tx.com.

Section iconCompany Overview

Headquarters
100 Technology Sq Cambridge, Massachusetts 02139 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $114M

    Semma Therapeutics has raised a total of $114M of funding over 1 rounds. Their latest funding round was raised on Nov 01, 2017 in the amount of $114Mas a Series B.

Section iconFunding & Financials

  • $114M

    Semma Therapeutics has raised a total of $114M of funding over 1 rounds. Their latest funding round was raised on Nov 01, 2017 in the amount of $114Mas a Series B.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.